AzTrials
AzTrials

Volume-Outcome Relationship in Pancreatic SurgeryPaSuTNCT06389890

Pancreatic Surgery - Optimal Caseload Thresholds and Predictive Accuracy

An observational study of Volume-Outcome Relationship in Pancreatic Surgery, run by Richard Hunger.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The main objective of the study is to identify the optimal annual number of cases in a hospital with regard to minimising hospital mortality in pancreatic surgery. In particular, the prognostic value of such case numbers will be analysed. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Pancreatic resection procedure
Type of treatment
Surgery or procedure
How many people
80,000 participants
Where
No sites listed yet
Study dates
1 Jan 2010to 31 Dec 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The study population encompasses all patients that underwent any pancreatic resection procedure in any German hospital (full survey of the German population).

Who may be able to join

  • at least 18 years old
  • any pancreatic resection procedure
  • operated at any German hospital

Who cannot join

  • any transplantation procedure
  • Inpatient admission for organ removal
  • no information on sex
  • no information on age

About this study

The main objective of the study is to identify the optimal annual number of cases in a hospital with regard to minimising hospital mortality in pancreatic surgery. In particular, the prognostic value of such case numbers will be analysed.

Read the detailed description

Main research questions:

  • Can specific intervention case numbers be identified that are suitable as thresholds for annual minimum volumes and are associated with significantly low hospital mortality?
  • Almost all previous studies on case number effects have only shown a descriptive association between the number of cases in a given year and the quality of outcomes in the same year. The aim of this study is to investigate whether the correlations described can be demonstrated when using the previous year's procedure volume as a predictor. The study seeks to answer whether the procedure caseload has predictive value, specifically the number of cases in one year and in-hospital mortality in the following year.

Background:

Numerous studies have demonstrated a correlation between the number of cases and the quality of outcomes for various surgical procedures. For instance, patients who underwent surgery in high-volume hospitals (HVH) had lower mortality rates, longer survival rates, lower complication rates, and lower reoperation rates than patients who underwent surgery in low-volume hospitals (LVH). To subdivide into HVHs and LVHs, either concrete case numbers or quartile or quintile limits with an equal number of operations or clinics per group wer used. The aim of the study is to objectively determine these limits using a spline-modeled caseload term, avoiding arbitrary decisions.

One limitation of the previous findings is that they may not be generalisable due to the use of a limited number of cases and outcome quality from the same year. However, it is important to note that the volume from the previous year is crucial in determining the predictive importance of caseload for future outcome quality. A recent study (in press) reported, that there are significant fluctuations in the quality of outcomes among HVHs, even between different years. Therefore, it was hypothesized that using the number of cases as a predictor of high-quality outcomes may lead to overestimation.

Methods:

The nationwide hospital billing data for Germany (DRG statistics) for the period 2010 to 2019 will be analysed. The risk-adjusted mortality rates are determined. For this purpose, logistic regression models are calculated that adjust the mortality risk for the following variables Sex, age, emergency of admission, year of resection, diagnosis (malign neoplasm vs. benign neoplasm vs. neoplasm of unclear dignity vs. acute pancreatitis vs. chronic pancreatitis vs. other pancreatic diseases), additional procedures (venous resections/ multivisceral resections/ arterial resections/ splenectomy/ cholecystectomy/ biliary drainage/ dialysis procedures) and selected comorbidities. To classify additional procedures in order to reflect extent of surgery and technical difficulty, a slight modification of the classification system as described in Mihaljevic et al, 2021 will be used (PMID: 33386130). The Elixhauser definitions are used for the comorbidities as described in Quan et al, 2005 (PMID: 16224307). The selection of comorbidities to be considered is based on the publication by Hunger et al, 2022 (PMID: 35525416).

The case number effect is modelled using natural cubic splines. The 10th, 20th, 40th, 60th, 80th and 90th case number percentiles are used as node points. The adjusted hospital mortality as a function of the number of cases is determined using Estimated Marginal Means. Local extremes (maxima and minima) in the splines are determined using 1st and 2nd graph derivate.

Various regression models are calculated using either the number of cases from the current year of operation or the previous year. The predictive accuracy of the models is determined using the established measures from signal detection theory (AUC, sensitivity, specificity, positive predictive value, negative predictive value). Subgroup analyses for individual resection procedures will be performed.

Being tested
Pancreatic resection procedure
Keywords
Outcome Assessment, General Surgery, Pancreatic Surgery, Public Health, Hospital Planning, Centralized Hospital Services

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pancreatic resection procedureProcedure or surgery

    Pancreatic resection procedure

Study groups in NCT06389890
Study groupRoleWhat they receive
All patients undergoing pancreatic surgeryAll patients with at least one pancreatic surgery procedure code
Receives: Procedure: Pancreatic resection procedure
Subgroup: Total pancreatectomyAll patients with at least one of the following pancreatic procedure codes (OPS-codes): '55250', '55251', '55252', '5525x', '5525y'
Receives: Procedure: Pancreatic resection procedure
Subgroup: PancreaticoduodenectomyAll patients with at least one of the following pancreatic procedure codes (OPS-codes): '55241', '55242', '55243'
Receives: Procedure: Pancreatic resection procedure
Subgroup: Segmental resectionAll patients with at least one of the following pancreatic procedure code (OPS-codes): '55244'
Receives: Procedure: Pancreatic resection procedure
Subgroup: Distal pancreatectomyAll patients with at least one of the following pancreatic procedure codes (OPS-codes): '55240', '552400', '552401', '552402'
Receives: Procedure: Pancreatic resection procedure
Subgroup: Other partial resectionsAll patients with at least one of the following pancreatic procedure codes (OPS-codes): '5524x', '5524y'
Receives: Procedure: Pancreatic resection procedure

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. In-hospital mortality

    Patient died during or after surgery

    Measured: within 30 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Apr 2024
  2. Study start1 Jan 2010
  3. Primary completion31 Dec 2019
  4. Study completion31 Dec 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
80,000 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06389890
Sponsor's protocol ID
PaSuTE
Acronym
PaSuT
Status last verified
Apr 2024
First submitted
15 Mar 2024
Last updated
29 Apr 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Data will be analyzed by controlled remote data analysis. The data is held exclusively by the Federal Statistical Office for scientific analyses. Direct access to or data sharing of individual patient data is prohibited by German law.

Questions about this trial

What is this clinical trial studying?

An observational study of Volume-Outcome Relationship in Pancreatic Surgery, run by Richard Hunger.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

In-hospital mortality (time frame: within 30 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Apr 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in